Ahmed Alotaibi: Does Donor Sex Influence Platelet Storage Quality
Ahmed Alotaibi, Senior Specialist (Blood bank and blood transfusion) at Afif General Hospital – Riyadh Third Health Cluster (Ministry of Health), shared a post on LinkedIn about a recent article by Fatemeh Arastehnazar et al, published in JCLA, adding:
“20 male donors. 20 female donors. Did their platelets behave differently during storage?
A small laboratory study explored whether donor sex was associated with changes in platelet concentrates during storage in plasma.
Researchers examined 40 concentrates at three storage time points, assessing metabolic activity, biochemical changes and oxidative damage.
One finding stood out:
Platelet concentrates from female donors had higher concentrations of malondialdehyde, a marker of lipid peroxidation, across the sampled storage period (p low 0.001).
The authors interpreted the overall findings as suggesting earlier and greater metabolic damage in female donor concentrates.
An interesting observation. But what does it mean for the blood bank?
It raises the possibility that donor characteristics contribute to differences in how platelet products tolerate storage.
It does not establish that platelets from female donors are less effective or less safe for patients.
The study assessed laboratory markers, not post-transfusion platelet increments, bleeding control or recipient outcomes.
And although the authors suggested prioritising femaled onor products for transfusion, this small study alone does not establish a basis for changing issue order.
The distinction matters:
A significant p value tells us about statistical evidence. It does not tell us how clinically important the difference is.
A difference in the storage bag is a research finding. Changing transfusion practice requires evidence that it matters to patients.”
Title: Evaluation of Function and Biochemical Parameters of Platelet Concentrates (PCs) Prepared From Blood Donors With a History of COVID-19 During the Platelet Storage
Authors: Fatemeh Arastehnazar, Mohammad Hessam Rafiee, Mohammad Reza Deyhim, Faezeh Ghasemi, Amir Teimourpour
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 14:09Stephen Alerhand: Acute Pulmonary Embolism vs Chronic Pulmonary Hypertension
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research